Shore Point Advisors’s Clorox CLX Stock Holding History

Shore Point Advisors’s Portfolio CLX Stock Details CLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-200	Closed	-$35K	–	61
2021 Q4	$35K	Buy	+200	New	+$33.3K	0.03%	83

Other funds holding CLX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Shore Point Advisors's CLX Position: Q1 2022 in Review

Shore Point Advisors sold out of Clorox (CLX) in Q1 2022, closing a stake of 200 shares — an estimated $35K sold.

Shore Point Advisors first reported a position in CLX in Q4 2021 and held it in 1 quarter. The position peaked at $35K in Q4 2021. 1,095 funds tracked by Wall St. Rank hold CLX as of Q1 2022.

Shore Point Advisors reported no remaining Clorox position as of Q1 2022 after selling out during the quarter.
Shore Point Advisors sold 200 Clorox shares in Q1 2022, an estimated $35K.
Shore Point Advisors first reported a position in Clorox in Q4 2021 and held it in 1 quarter.
Shore Point Advisors's Clorox position peaked at $35K in Q4 2021.
1,095 funds tracked by Wall St. Rank held Clorox as of Q1 2022.

Based on Shore Point Advisors's 13F filing for Q1 2022, filed 26 Apr 2022.